Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Cerebral Haemorrhage to Target Secondary Injury from Neuroinflammation (Phase II)
2021-000324-36Phase 2Active
- Sponsor
- Radboudumc
- Start
- Mar 2022
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of anakinra in intracerebral hemorrhage (ICH) (3 arms), sponsored by Radboudumc. Primary endpoint: Oedema extension distance (OED) on MRI. Started Mar 2022; status: active.
02
Drugs
anakinra
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2021-000324-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000324-36.